• DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival 

      Pedersen, Christine Aaserød; Cao, Maria Dung; Fleischer, Thomas; Rye, Morten Beck; Knappskog, Stian; Eikesdal, Hans Petter; Lønning, Per Eystein; Tost, Jörg; Kristensen, Vessela N.; Tessem, May-Britt; Giskeødegård, Guro F.; Bathen, Tone Frost (Peer reviewed; Journal article, 2022)
      Background Locally advanced breast cancer is a heterogeneous disease with respect to response to neoadjuvant chemotherapy (NACT) and survival. It is currently not possible to accurately predict who will benefit from the ...
    • From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients 

      Tune, Benedicte Grebstad; Sareen, Heena; Powter, Branka; Kahana-Edwin, Smadar; Cooper, Adam; Koh, Eng-Siew; Lee, Cheok S.; Po, Joseph W.; McCowage, Geoff; Dexter, Mark; Cain, Lucy; O’Neill, Geraldine; Prior, Victoria; Karpelowsky, Jonathan; Tsoli, Maria; Baumbusch, Lars Oliver; Ziegler, David; Roberts, Tara L.; DeSouza, Paul; Becker, Therese M.; Ma, Yafeng (Peer reviewed; Journal article, 2023)
      Genetic histone variants have been implicated in cancer development and progression. Mutations affecting the histone 3 (H3) family, H3.1 (encoded by HIST1H3B and HIST1H3C) and H3.3 (encoded by H3F3A), are mainly associated ...